Cord blood cells aim to heal Radiation-Damaged intestines
NCT ID NCT07175207
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-phase trial tests whether umbilical cord blood cells can safely help people with chronic radiation enteritis, a painful gut condition caused by cancer radiation therapy. Ten adults who have had pelvic or abdominal radiation will receive three weekly infusions of these cells. Researchers will monitor for side effects and look for signs of healing in the gut lining and symptom relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- umbilical cord blood mononuclear cells (UCB-MNCs)
- What this could lead to
- If it works, this could point toward a new treatment to repair intestinal damage from radiation therapy.
- What could go wrong
- This is a very early, small trial with only 10 people. It is designed mainly to check safety, not to prove effectiveness. The treatment may not work or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RADIATION ENTERITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China